Under the terms of the agreement, Dr. Reddy’s will not launch its generic rivastigmine tartrate capsules until sometime before the expiry of the orange book patents claiming rivastigmine.
Rivastigmine tartrate capsules, the generic version of the Novartis product Exelon, are indicated for the treatment of mild-to-moderate Alzheimer’s disease, dementia.